Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Harefuah|January 1, 1980
[Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis]M Talpaz
British Journal of Clinical Practice. Supplement|March 1, 1988
Activity of alpha-interferons in chronic myelogenous leukaemiaM Talpaz
The American Journal of the Medical Sciences|August 1, 1988
The activity of alpha interferons in chronic myelogenous leukemiaM Talpaz
Cancer Treatment Reviews|January 1, 1988
Clinical studies of alpha-interferons in chronic myelogenous leukemiaM Talpaz
Seminars in Hematology|August 30, 2001
Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibitionM Talpaz
Seminars in Oncology|December 1, 1994
Use of interferon in the treatment of chronic myelogenous leukemiaM Talpaz
Annals of Internal Medicine|May 1, 1995
Low-dose interferon-alpha in chronic myeloid leukemiaM Talpaz, H Kantarjian
Harefuah|February 1, 1979
[Duration of hospitalization and convalescence of patients with acute myocardial infarction]Z Bentwich, M Talpaz
Harefuah|February 1, 1979
[Early ambulation after acute myocardial infarction]M Talpaz, Z Bentwich
British Journal of Haematology|October 1, 1991
The molecular pathology of chronic myelogenous leukaemiaR Kurzrock, M Talpaz
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Harefuah|January 1, 1980
[Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis]M Talpaz
British Journal of Clinical Practice. Supplement|March 1, 1988
Activity of alpha-interferons in chronic myelogenous leukaemiaM Talpaz
The American Journal of the Medical Sciences|August 1, 1988
The activity of alpha interferons in chronic myelogenous leukemiaM Talpaz
Cancer Treatment Reviews|January 1, 1988
Clinical studies of alpha-interferons in chronic myelogenous leukemiaM Talpaz
Seminars in Hematology|August 30, 2001
Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibitionM Talpaz
Seminars in Oncology|December 1, 1994
Use of interferon in the treatment of chronic myelogenous leukemiaM Talpaz
Annals of Internal Medicine|May 1, 1995
Low-dose interferon-alpha in chronic myeloid leukemiaM Talpaz, H Kantarjian
Harefuah|February 1, 1979
[Duration of hospitalization and convalescence of patients with acute myocardial infarction]Z Bentwich, M Talpaz
Harefuah|February 1, 1979
[Early ambulation after acute myocardial infarction]M Talpaz, Z Bentwich
British Journal of Haematology|October 1, 1991
The molecular pathology of chronic myelogenous leukaemiaR Kurzrock, M Talpaz
Pageof 35